Moreover, GAL-8 showed a 1.890-fold greater risk for diagnosing glioma, a 1.911-fold higher risk also for malignant progression, a 2.167-fold greater risk for developing GBM, and a 1.627-fold higher risk for the presence of glioma in the temporoparietal region. This evidence concerns the gene LGALS8 and glioblastoma.